Smith & Nephew (SNN) Amortization of Deferred Charges (2018 - 2024)
Smith & Nephew (SNN) posted quarterly Amortization of Deferred Charges of $61.0 million for Q4 2024, up 38.64% year-on-year from $44.0 million in Q1 2024, and up 38.64% on a QoQ basis from $44.0 million in Q4 2023.
Smith & Nephew (SNN) Amortization of Deferred Charges (2018 - 2024) Analysis & Trends
Smith & Nephew (SNN) has reported Amortization of Deferred Charges for 7 consecutive years, with $61.0 million the latest figure, recorded in Q4 2024.
- Quarterly Amortization of Deferred Charges rose 38.64% year-over-year to $61.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $176.0 million (up 29.41% YoY) and the FY2025 annual result came in at $112.0 million, down 7.44% from the prior year.
- Amortization of Deferred Charges grew to $61.0 million in Q4 2024 per SNN's latest filing, from $44.0 million in the prior quarter.
- Over the last five years, Amortization of Deferred Charges for SNN reached as high as $61.0 million in Q4 2024 and fell as low as $21.0 million in Q4 2020.
- A 5-year average of $39.4 million and a median of $39.0 million in 2021 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2021 — Amortization of Deferred Charges jumped 85.71% — and 2022, when it decreased 17.95%.
- Year by year, Amortization of Deferred Charges stood at $21.0 million in 2020, then jumped by 85.71% to $39.0 million in 2021, then fell by 17.95% to $32.0 million in 2022, then jumped by 37.5% to $44.0 million in 2023, then surged by 38.64% to $61.0 million in 2024.
- According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $61.0 million, $44.0 million, and $32.0 million for Q4 2024, Q4 2023, and Q4 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 61.00 Mn |
| Dec 31, 2024 | 61.00 Mn |
| Dec 31, 2023 | 44.00 Mn |
| Dec 31, 2023 | 44.00 Mn |
| Dec 31, 2022 | 32.00 Mn |
| Dec 31, 2022 | 32.00 Mn |
| Dec 31, 2021 | 39.00 Mn |
| Dec 31, 2021 | 39.00 Mn |
| Dec 31, 2020 | 21.00 Mn |
| Dec 31, 2020 | 21.00 Mn |
| Dec 31, 2019 | 25.00 Mn |
| Dec 31, 2019 | 25.00 Mn |
| Dec 31, 2018 | 51.00 Mn |
| Dec 31, 2018 | 51.00 Mn |